It is a multitarget oral tyrosine-kinase inhibitor (TKI) that selectively blocks signal transduction from receptor tyrosine kinase (RTK), contributing to tumor cell proliferation, tumor angiogenesis, and metastasis. This evidence concerns the gene NTRK1 and neoplasm.